DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies.
Le Pogam C, Patel S, Gorombei P, Guerenne L, Krief P, Omidvar N, Tekin N, Bernasconi E, Sicre F, Schlageter MH, Chopin M, Noguera ME, West R, Abu A, Mathews V, Pla M, Fenaux P, Chomienne C, Padua RA.
Le Pogam C, et al. Among authors: chomienne c.
Oncotarget. 2015 Oct 20;6(32):32494-508. doi: 10.18632/oncotarget.5572.
Oncotarget. 2015.
PMID: 26378812
Free PMC article.